Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients
Wei-Jia Yang,1,* Lian-dong Shi,2,* Ye Liang,3,* Li-ming Liang,4,* Hao Zhang,5 Li Wang,2 Qian Zhou1 1Department of Eugenics and Genetics, Guilin People's Hospital, Guilin, Guangxi Zhuang Autonomous Region, 541002, People's Republic of China; 2Department of Ul...
Saved in:
Main Authors: | Yang WJ (Author), Shi LD (Author), Liang Y (Author), Liang LM (Author), Zhang H (Author), Wang L (Author), Zhou Q (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy of thalidomide for various genotypes of beta thalassemia
by: Wei-jia Yang, et al.
Published: (2024) -
Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis
by: Yanfei Lu, et al.
Published: (2022) -
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
by: Yaocheng Chen, et al.
Published: (2020) -
Efficacy and safety of thalidomide in two sisters with severe refractory polyarteritis nodosa (PAN)
by: Vitale A, et al.
Published: (2008) -
Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
by: Xinyu Li, et al.
Published: (2021)